Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Stephens JimPresident, CRM & Neuro | Tax withholding | F | $38K 447 sh | Jan 21, 2026 |
| 16 | Senn AndrewSVP, Strategy and Business Dev | Tax withholding | F | $62K 724 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Garefis AmyEVP, Chief People Officer | Open-market sale · 10b5-1 plan | SELL | $7,521 2,847 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.68M 632.9K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.64M 632.9K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 16 | Earnshaw Timothy JSVP, CAO & Treasurer | Tax withholding | F | $126K 4,191 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Selecky ChristobelDirector | Open-market sale · 10b5-1 plan | SELL | $188K 25.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Shimanovsky Boris F.EVP, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $15K 5,650 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Thornock Tai A.Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $27K 1,100 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 16 | Sakamoto Ryan T.EVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $5,673 2,169 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 16 | Peil A JosephExecutive VP and CIO | Tax withholding | F | $186K 6,183 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 15 | Weitzel Gregory ThomasCFO | Option exercise | M | — 2,254 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Nixon Gordon M.Director | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Mills Cheryl DDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Trotta MatteoEVP, GM, Dermatology US | Grant or award | A | — 8,542 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Moore MichaelPresident | Disposition to issuer | D | $49K 6,735 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Bronstein ManuelDirector | Grant or award | A | — 44 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Cambre JeromeVice President of Sales | Disposition to issuer | D | $16K 2,132 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Macdonald AndrewSee Remarks | Option exercise | M | — 3,841 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Trahan JeremyGeneral Counsel | Option exercise | M | — 1,221 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Comerchero Marc D.Principal Accounting Officer | Grant or award | A | — 179 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Hazelbaker JillSee Remarks | Option exercise | M | — 2,546 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Senn AndrewSVP, Strategy and Business Dev | Grant or award | A | — 3,497 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Fitzgerald TraeChief Financial Officer | Tax withholding | F | $23K 3,132 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Carr TerenceEVP, Qlty & Regulatory Affairs | Grant or award | A | — 1,554 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Blackwood Lindsay K.SVP, Gen Counsel & Secretary | Grant or award | A | — 2,720 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Mills Desmond JSVP & Chief Accounting Officer | Option exercise | M | — 953 sh | Jan 21, 2026 traded Jan 18, 2026 |
| 15 | Macdonald AndrewSee Remarks | Option exercise | M | — 2,472 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Trahan JeremyGeneral Counsel | Option exercise | M | — 4,884 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Moore MichaelPresident | Option exercise | M | — 6,735 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Cambre JeromeVice President of Sales | Option exercise | M | — 8,525 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Weitzel Gregory ThomasCFO | Option exercise | M | — 14.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Trahan JeremyGeneral Counsel | Disposition to issuer | D | $8,950 1,221 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 15 | Kushel J. RichardSenior Managing Director | Grant or award | A | — 2,243 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Gerber MurryDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Macdonald AndrewSee Remarks | Option exercise | M | — 2,472 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Halio CareyGlobal Treasurer | Grant or award | A | — 2,651 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Krishnamurthy NikkiSVP and Chief People Officer | Tax withholding | F | $24K 280 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Weitzel Gregory ThomasCFO | Option exercise | M | — 2,159 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Kapito RobertDirector, President | Grant or award | A | — 5,127 sh | Jan 21, 2026 traded Jan 16, 2026 |